Insiders Novo Nordisk A/S

Equities

NOVO B

DK0062498333

Pharmaceuticals

Market Closed - Nasdaq Copenhagen Other stock markets 11:20:00 2026-04-14 EDT			5-day change	1st Jan Change
246.15 ^DKK	+3.32%		+4.70%	-24.32%

01:45am	SB1 Markets initiates coverage on Novo Nordisk with Buy rating and DKK 280 price target	FW
01:02am	Nordic Equities in North America - Astra Zeneca Gains 0.9 Percent	FW

Insiders

04-13	Lineage Cell Therapeutics, Inc. Announces Formation of Scientific Advisory Board and Executive Appointment	CI
04-07	Lytix Biopharma AS Announces Appointment of Renée Christine Amundsen as Chief Operating Officer, Effective April 7, 2026	CI
04-01	Novo's New US Chief on Lilly's Rival Weight-Loss Pill	MT
03-27	Novo Nordisk AS Announces Board Appointments	CI
03-26	Novo Nordisk A/S Approves Board Changes	CI
03-25	Rani Therapeutics Holdings, Inc. Appoints Jesper Høiland as Head of Strategy	CI
03-09	Global markets live: Live Nation, Eli Lilly, Amazon, Microsoft, ABB…
03-02	Novo Nordisk A/S Announces Changes of Employee Representatives to the Board of Directors	CI
02-25	Sleep Cycle Announces Executive Appointments	CI
02-24	Novo's stumbles burnish Lilly's widening lead in weight-loss drugs	RE
02-23	Novo Nordisk's CEO says still 'incredibly optimistic' about CagriSema	RE
02-23	Novo Nordisk's CEO: We need to be aware that there is an abnormality with how the comparator drug has performed in the study	RE
02-23	Novo Nordisk's CEO: I am still incredibly optimistic about Cagrisema	RE
02-23	Novo Nordisk's CEO: We strongly believe that Cagrisema has right now the best weight efficacy than any product currently on the market	RE
02-23	Novo Nordisk's chief scientific officer: assuming that there is further weight loss potential to be had with Cagrisema	RE
02-20	Novo Nordisk board proposes re-election of Lars Rebien Sorensen as chair	RE
02-20	Novo Nordisk nominates two drug industry veterans to strengthen board	RE
02-17	Camurus Names Chief Corporate Development Officer	MT
02-17	Camurus Appoints Jane Buus Laursen as Chief Corporate Development Officer, Effective March 23, 2026	CI
02-12	Sanofi ousts CEO Hudson after stalled turnaround at vaccine giant	RE
02-09	Novo Says It's Suing Hims to Halt Obesity Drug Copycats	MT
02-09	Hims & Hers Stops Selling Wegovy Copycat Weight-Loss Pill	MT
02-09	Global markets live: Alphabet, Meta, Eli Lilly, Uber, Ocado…
02-09	Exchange-Traded Funds, Equity Futures Lower Pre-Bell Monday Ahead of Data-Heavy Week	MT
02-09	Wall St struggles for direction as investors await key economic data	RE